OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Role of molecular genetics in the clinical management of cholangiocarcinoma
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 23
Nicola Normanno, Erika Martinelli, Davide Melisi, et al.
ESMO Open (2022) Vol. 7, Iss. 3, pp. 100505-100505
Open Access | Times Cited: 23
Showing 23 citing articles:
Cholangiocarcinoma: Recent Advances in Molecular Pathobiology and Therapeutic Approaches
Divya Khosla, Shagun Misra, Pek Lim Chu, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 801-801
Open Access | Times Cited: 11
Divya Khosla, Shagun Misra, Pek Lim Chu, et al.
Cancers (2024) Vol. 16, Iss. 4, pp. 801-801
Open Access | Times Cited: 11
PD-L1 evaluation in the gastrointestinal tract: from biological rationale to its clinical application
Luca Mastracci, Federica Grillo, Paola Parente, et al.
Pathologica (2022) Vol. 114, Iss. 5, pp. 352-364
Open Access | Times Cited: 24
Luca Mastracci, Federica Grillo, Paola Parente, et al.
Pathologica (2022) Vol. 114, Iss. 5, pp. 352-364
Open Access | Times Cited: 24
Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 14
Albrecht Stenzinger, Arndt Vogel, Ulrich Lehmann, et al.
Cancer Treatment Reviews (2023) Vol. 122, pp. 102649-102649
Open Access | Times Cited: 14
Practical guidelines for molecular testing of cholangiocarcinoma in clinical practice: Italian experts’ position paper
Matteo Fassan, Valentina Angerilli, Nicola Normanno, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104224-104224
Open Access | Times Cited: 5
Matteo Fassan, Valentina Angerilli, Nicola Normanno, et al.
Critical Reviews in Oncology/Hematology (2024) Vol. 194, pp. 104224-104224
Open Access | Times Cited: 5
Prognostic influence of multiple hepatic lesions in resectable intrahepatic cholangiocarcinoma: A systematic review and meta-analysis
Hannes Jansson, Christina Villard, Lynn E. Nooijen, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 4, pp. 688-699
Open Access | Times Cited: 11
Hannes Jansson, Christina Villard, Lynn E. Nooijen, et al.
European Journal of Surgical Oncology (2023) Vol. 49, Iss. 4, pp. 688-699
Open Access | Times Cited: 11
Extrahepatic Distal Cholangiocarcinoma vs. Pancreatic Ductal Adenocarcinoma: Histology and Molecular Profiling for Differential Diagnosis and Treatment
Αναστάσιος Γκουντάκος, Filippo Maria Martelli, Nicola Silvestris, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1454-1454
Open Access | Times Cited: 7
Αναστάσιος Γκουντάκος, Filippo Maria Martelli, Nicola Silvestris, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1454-1454
Open Access | Times Cited: 7
FGFR2 testing in cholangiocarcinoma: translating molecular studies into clinical practice
Valentina Angerilli, Lorenzo Fornaro, Francesco Pepe, et al.
Pathologica (2023) Vol. 115, Iss. 2, pp. 71-82
Open Access | Times Cited: 7
Valentina Angerilli, Lorenzo Fornaro, Francesco Pepe, et al.
Pathologica (2023) Vol. 115, Iss. 2, pp. 71-82
Open Access | Times Cited: 7
Tubulocystic Carcinoma of Bile Ducts
Francesca Masetto, Andrea Mafficini, Burcu Saka, et al.
The American Journal of Surgical Pathology (2024) Vol. 48, Iss. 9, pp. 1082-1092
Closed Access | Times Cited: 2
Francesca Masetto, Andrea Mafficini, Burcu Saka, et al.
The American Journal of Surgical Pathology (2024) Vol. 48, Iss. 9, pp. 1082-1092
Closed Access | Times Cited: 2
Pemigatinib: A Review in Advanced Cholangiocarcinoma
James E. Frampton
Targeted Oncology (2024) Vol. 19, Iss. 1, pp. 107-114
Closed Access | Times Cited: 1
James E. Frampton
Targeted Oncology (2024) Vol. 19, Iss. 1, pp. 107-114
Closed Access | Times Cited: 1
Immunohistochemistry: The Importance of Precision Ontology to Precision Oncology
Emina Torlakovic, Carol C. Cheung
Applied immunohistochemistry & molecular morphology (2024)
Closed Access | Times Cited: 1
Emina Torlakovic, Carol C. Cheung
Applied immunohistochemistry & molecular morphology (2024)
Closed Access | Times Cited: 1
Practical considerations for pathological diagnosis and molecular profiling of cholangiocarcinoma: an expert review for best practices
Matthew Evans, Timothy J. Kendall
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 5, pp. 393-408
Closed Access | Times Cited: 1
Matthew Evans, Timothy J. Kendall
Expert Review of Molecular Diagnostics (2024) Vol. 24, Iss. 5, pp. 393-408
Closed Access | Times Cited: 1
Long-Term Survivor of Intrahepatic Cholangiocarcinoma for over 18 Years: Case Study with Longitudinal Histo-molecular and Tumor Immune Microenvironment Characterization and Systematic Review of the Literature
Paola Mattiolo, Mario De Bellis, Andrea Mafficini, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 4, pp. 1634-1646
Open Access | Times Cited: 1
Paola Mattiolo, Mario De Bellis, Andrea Mafficini, et al.
Journal of Gastrointestinal Cancer (2024) Vol. 55, Iss. 4, pp. 1634-1646
Open Access | Times Cited: 1
Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study
Yoshitaro Shindo, Hiroaki Nagano, Masashi Kanai, et al.
Oncology Reports (2023) Vol. 49, Iss. 2
Open Access | Times Cited: 4
Yoshitaro Shindo, Hiroaki Nagano, Masashi Kanai, et al.
Oncology Reports (2023) Vol. 49, Iss. 2
Open Access | Times Cited: 4
Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology
Wangyang Chen, Dongchao Xu, Qiang Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114697-114697
Open Access | Times Cited: 3
Wangyang Chen, Dongchao Xu, Qiang Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114697-114697
Open Access | Times Cited: 3
Novel cell subtypes of SPP1 + S100P+, MS4A1-SPP1 + S100P+ were key subpopulations in intrahepatic cholangiocarcinoma
Zixue Xuan, Linqing Liu, Guobing Zhang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130420-130420
Closed Access | Times Cited: 2
Zixue Xuan, Linqing Liu, Guobing Zhang, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2023) Vol. 1867, Iss. 9, pp. 130420-130420
Closed Access | Times Cited: 2
Diagnosis and treatment of cholangiocarcinoma in Italy: A Delphi consensus statement
Lorenza Rimassa, Giovanni Brandi, Monica Niger, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 192, pp. 104146-104146
Open Access | Times Cited: 2
Lorenza Rimassa, Giovanni Brandi, Monica Niger, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 192, pp. 104146-104146
Open Access | Times Cited: 2
Kolanjiyokarsinom ve Hepatoselüler Karsinom Hastalarında Farklı Genler Tarafından Tetiklenen Ortak Biyolojik Yolaklar
Gizem Ayna Duran
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi (2024) Vol. 11, Iss. 1, pp. 141-149
Open Access
Gizem Ayna Duran
Celal Bayar Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi (2024) Vol. 11, Iss. 1, pp. 141-149
Open Access
CT-based radiogenomics of intrahepatic cholangiocarcinoma
Luca Viganò, Valentina Zanuso, Francesco Fiz, et al.
Digestive and Liver Disease (2024)
Closed Access
Luca Viganò, Valentina Zanuso, Francesco Fiz, et al.
Digestive and Liver Disease (2024)
Closed Access
The Italian Rare Biliary tract Cancer initiative (IRaBiCa): A multicentric observational study of Gruppo Oncologico dell’Italia Meridionale (GOIM) in collaboration with Gruppo Italiano Colangiocarcinoma (GICO)
Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, et al.
Tumori Journal (2024) Vol. 110, Iss. 3, pp. 203-208
Closed Access
Desirèe Speranza, Elena Sapuppo, Giuseppe Aprile, et al.
Tumori Journal (2024) Vol. 110, Iss. 3, pp. 203-208
Closed Access
Molecular biology of cholangiocarcinoma and its implications for targeted therapy in patient management
Timothy Gilbert, Laura E. Randle, Marc Quinn, et al.
European Journal of Surgical Oncology (2024), pp. 108352-108352
Closed Access
Timothy Gilbert, Laura E. Randle, Marc Quinn, et al.
European Journal of Surgical Oncology (2024), pp. 108352-108352
Closed Access
The biliary tree musketeers: cholangiocarcinoma – one name for all, but at least three different diseases with distinct targets
Lidiane Vieira Marins, Camila Motta Venchiarutti Moniz, Cecília Souza Freire, et al.
Surgical and Experimental Pathology (2024) Vol. 7, Iss. 1
Open Access
Lidiane Vieira Marins, Camila Motta Venchiarutti Moniz, Cecília Souza Freire, et al.
Surgical and Experimental Pathology (2024) Vol. 7, Iss. 1
Open Access
Which therapy in biliary tract cancer? Review of main concerns in diagnosis and choice of therapy in advanced setting, current standard, and new options
Ester Oneda, Serena Astore, Laura Gandolfi, et al.
Expert Opinion on Pharmacotherapy (2024)
Open Access
Ester Oneda, Serena Astore, Laura Gandolfi, et al.
Expert Opinion on Pharmacotherapy (2024)
Open Access
Survival trends over 20 years in patients with advanced cholangiocarcinoma: Results from a national retrospective analysis of 922 cases in Italy
Andrea Casadei‐Gardini, Francesco Leone, Giovanni Brandi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Andrea Casadei‐Gardini, Francesco Leone, Giovanni Brandi, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
